A business in context

COCH research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-08 · 8005 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. DEF 14A · Proxy statement

    Report date 2026-10-12 · 0001213900-26-095756

  2. 8-K · Current report

    Report date 2026-08-24 · 0001213900-26-094447 · Items 5.02,9.01

  3. 4 · Ownership change

    Report date 2026-08-24 · 0000914190-26-000137

  4. 8-K · Current report

    Report date 2026-08-10 · 0001213900-26-087221 · Items 2.02,9.01

  5. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001213900-26-086974

  6. 8-K · Current report

    Report date 2026-06-24 · 0001213900-26-073659 · Items 1.02,9.01

  7. 8-K · Current report

    Report date 2026-06-19 · 0001213900-26-072033 · Items 5.02,9.01

  8. 4 · Ownership change

    Report date 2026-06-19 · 0000914190-26-000100

  9. 4 · Ownership change

    Report date 2026-05-29 · 0000914190-26-000095

  10. 8-K · Current report

    Report date 2026-05-19 · 0001213900-26-060556 · Items 3.01

  11. 8-K · Current report

    Report date 2026-05-12 · 0001213900-26-058429 · Items 5.02,5.07,9.01

  12. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001213900-26-054209

  13. 8-K · Current report

    Report date 2026-05-11 · 0001213900-26-054185 · Items 2.02,9.01

  14. 8-K · Current report

    Report date 2026-04-15 · 0001213900-26-046197 · Items 5.02,9.01

  15. 4 · Ownership change

    Report date 2026-04-15 · 0000914190-26-000077

  16. 10-K/A · Annual report

    Report date 2025-12-31 · 0001213900-26-043011

  17. DEF 14A · Proxy statement

    Report date 2026-05-12 · 0001213900-26-039310

  18. 8-K · Current report

    Report date 2026-03-25 · 0001213900-26-037419 · Items 4.01,9.01

  19. 8-K · Current report

    Report date 2026-03-23 · 0001213900-26-035483 · Items 2.02,9.01

  20. 10-K · Annual report

    Report date 2025-12-31 · 0001213900-26-032683

  21. 8-K · Current report

    Report date 2026-02-23 · 0001213900-26-021116 · Items 3.01,8.01,9.01

  22. 4 · Ownership change

    Report date 2026-02-12 · 0001104659-26-016182

  23. 4 · Ownership change

    Report date 2026-02-12 · 0000914190-26-000028

  24. 4 · Ownership change

    Report date 2026-02-12 · 0000914190-26-000027

  25. 4 · Ownership change

    Report date 2026-02-12 · 0000914190-26-000026

  26. 8-K · Current report

    Report date 2026-02-11 · 0001213900-26-016584 · Items 1.01,8.01,9.01

  27. 8-K · Current report

    Report date 2026-02-05 · 0001213900-26-014878 · Items 5.02,9.01

  28. 8-K · Current report

    Report date 2025-12-18 · 0001213900-25-126032 · Items 1.01,9.01

  29. 8-K · Current report

    Report date 2025-12-16 · 0001213900-25-121987 · Items 7.01,9.01

  30. 8-K · Current report

    Report date 2025-11-26 · 0001213900-25-117805 · Items 5.07,9.01

  31. 8-K · Current report

    Report date 2025-11-19 · 0001213900-25-114725 · Items 3.01

  32. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001213900-25-107902

  33. 8-K · Current report

    Report date 2025-11-10 · 0001213900-25-107898 · Items 2.02,9.01

  34. 8-K · Current report

    Report date 2025-10-23 · 0001213900-25-102828 · Items 3.01,8.01,9.01

  35. DEF 14A · Proxy statement

    Report date 2025-11-26 · 0001213900-25-099960

  36. 8-K · Current report

    Report date 2025-10-07 · 0001213900-25-097600 · Items 1.01,3.02,8.01,9.01

  37. 8-K · Current report

    Report date 2025-10-07 · 0001213900-25-096845 · Items 8.01,9.01

  38. 8-K · Current report

    Report date 2025-09-22 · 0001213900-25-090373 · Items 1.01,3.02,8.01,9.01

  39. 8-K · Current report

    Report date 2025-09-19 · 0001213900-25-089225 · Items 8.01,9.01

  40. 8-K · Current report

    Report date 2025-09-04 · 0001213900-25-086268 · Items 1.01,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 0 transaction rows0SGrant / award: 4 transaction rows4AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

4 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-06-19
2026-06-23
Lucas Brent T.A · Grant / award
Acquired
Stock Option (right to buy)
Derivative security
1000000.00.0
2026-06-19
2026-06-23
Lucas Brent T.A · Grant / award
Acquired
Restricted Stock Units
Derivative security
1000000.00.0
2026-05-29
2026-06-04
Lucas Brent T.A · Grant / award
Acquired
Class A Common Stock32856.00.6
2026-04-15
2026-04-17
McKhann ChasA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
100000.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001840877Envoy Medical, Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names
  • Anzu Special Acquisition Corp I · former SEC name · 2021-01-19 to 2023-09-29

Revenue in constant purchasing power

USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$225.0K$239.5K
2023-12-31$316.0K$346.3K
2022-12-31$237.0K$270.4K

Bureau of Labor Statistics · retrieved 2026-09-08 · 9 selected series; gaps remain missing

Explore the CPI history ↗